Avian Influenza

Aviron Announces Vaccine Collaboration

Published in Vaccine Weekly, February 16th, 1998

Aviron announced that it is working with the U.S. National Institutes of Health (NIH) to collaborate with the U.S. Centers for Disease Control and Prevention (CDC) in preparing two vaccine candidates, or source material, for potential use in the event of a pandemic of the "Hong Kong flu" resulting from the avian A/Hong Kong/97 (H5N1) influenza virus.

The Aviron research team provided an update on their progress to the U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee, which held a regularly scheduled meeting on February 3, 1998, to discuss the influenza virus vaccine formulation for the 1998-99 flu season.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1998-02-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry